Cardlytics, Inc.
NASDAQ:CDLX
3.86 (USD) • At close November 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 309.204 | 298.542 | 267.116 | 186.892 | 210.43 | 150.684 | 130.365 | 112.821 | 77.634 |
| Cost of Revenue
| 178.826 | 185.91 | 163.776 | 123.618 | 130.973 | 96.003 | 80.259 | 72.412 | 52.494 |
| Gross Profit
| 130.378 | 112.632 | 103.34 | 63.274 | 79.457 | 54.681 | 50.106 | 40.409 | 25.14 |
| Gross Profit Ratio
| 0.422 | 0.377 | 0.387 | 0.339 | 0.378 | 0.363 | 0.384 | 0.358 | 0.324 |
| Reseach & Development Expenses
| 51.352 | 54.435 | 38.104 | 17.532 | 11.699 | 16.21 | 12.15 | 13.902 | 11.604 |
| General & Administrative Expenses
| 71.434 | 81.446 | 66.222 | 46.532 | 36.72 | 34.228 | 20.1 | 21.355 | 18.197 |
| Selling & Marketing Expenses
| 44.803 | 74.745 | 65.996 | 45.307 | 43.828 | 41.878 | 31.927 | 31.261 | 32.784 |
| SG&A
| 116.237 | 156.191 | 132.218 | 91.839 | 80.548 | 76.106 | 52.027 | 52.616 | 50.981 |
| Other Expenses
| 98.459 | 37.544 | 29.871 | 7.826 | 4.535 | -2.101 | 6.278 | -13.262 | -0.432 |
| Operating Expenses
| 195.835 | 248.17 | 200.193 | 117.197 | 96.782 | 95.598 | 67.205 | 70.737 | 64.779 |
| Operating Income
| -135.67 | -135.538 | -96.853 | -53.923 | -17.325 | -40.917 | -17.099 | -56.232 | -39.639 |
| Operating Income Ratio
| -0.439 | -0.454 | -0.363 | -0.289 | -0.082 | -0.272 | -0.131 | -0.498 | -0.511 |
| Total Other Income Expenses Net
| 0.968 | -8.932 | -13.83 | -1.499 | 0.181 | -12.125 | -2.542 | -19.464 | -1.002 |
| Income Before Tax
| -134.702 | -466.71 | -136.429 | -55.422 | -17.144 | -53.042 | -19.641 | -75.696 | -40.641 |
| Income Before Tax Ratio
| -0.436 | -1.563 | -0.511 | -0.297 | -0.081 | -0.352 | -0.151 | -0.671 | -0.523 |
| Income Tax Expense
| 0 | -1.446 | -7.864 | 3.048 | 0.548 | -12.125 | 5.743 | 32.106 | -0.016 |
| Net Income
| -134.702 | -465.264 | -128.565 | -58.47 | -17.692 | -53.042 | -19.641 | -75.696 | -40.625 |
| Net Income Ratio
| -0.436 | -1.558 | -0.481 | -0.313 | -0.084 | -0.352 | -0.151 | -0.671 | -0.523 |
| EPS
| -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.4 | -2.9 |
| EPS Diluted
| -3.69 | -13.92 | -3.99 | -2.15 | -0.75 | -2.78 | -1.01 | -5.4 | -2.9 |
| EBITDA
| -99.004 | -418.976 | -89.913 | -39.51 | -12.79 | -45.97 | -8.374 | -24.004 | -37.445 |
| EBITDA Ratio
| -0.32 | -0.307 | -0.229 | -0.226 | -0.061 | -0.205 | -0.103 | -0.002 | -0.494 |